Journal article
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
- Abstract:
-
Invariant natural killer T (iNKT) cells are powerful immunomodulatory cells that in mice regulate a variety of immune responses, including acute GVHD (aGVHD). However, their clinical relevance and in particular their role in clinical aGVHD are not known. We studied whether peripheral blood stem cell (PBSC) graft iNKT-cell dose affects on the occurrence of clinically significant grade II-IV aGVHD in patients (n = 57) undergoing sibling, HLA-identical allogeneic HSCT. In multivariate analysis, ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 305.9KB)
-
- Publisher copy:
- 10.1182/blood-2011-11-389304
Authors
Funding
Leukaemia and Lymphoma Research
More from this funder
Leuka
More from this funder
National Institute of Health Research
More from this funder
Bibliographic Details
- Publisher:
- American Society for Hematology Publisher's website
- Journal:
- Blood Journal website
- Volume:
- 119
- Issue:
- 21
- Pages:
- 5030-5036
- Publication date:
- 2012-05-01
- Acceptance date:
- 2012-02-16
- DOI:
- EISSN:
-
1528-0020
- ISSN:
-
0006-4971
- Source identifiers:
-
508070
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:508070
- UUID:
-
uuid:8b0e859c-191c-4bb1-b746-9ced564d8796
- Local pid:
- pubs:508070
- Deposit date:
- 2016-03-09
Terms of use
- Copyright holder:
- American Society of Hematology
- Copyright date:
- 2012
- Notes:
- © 2012 by The American Society of Hematology
If you are the owner of this record, you can report an update to it here: Report update to this record